MIL:1CRL's Quick Ratio is ranked worse than 71.16% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.73
vs MIL:1CRL: 1.03
Charles River Laboratories International (MIL:1CRL) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Charles River Laboratories International Quick Ratio Related Terms
Charles River Laboratories International Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International Quick Ratio Chart
Charles River Laboratories International Annual Data
MIL:1CRL vs RVTY, QGEN, ICLR: Quick Ratio Comparison
For the Diagnostics & Research subindustry, Charles River Laboratories International's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's Quick Ratio falls into.
Charles River Laboratories International Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (MIL:1CRL) has a Quick Ratio of 1.03 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Charles River Laboratories International and its competitors. This is 15% below median its historical median of 1.21. Over the past decade, Charles River Laboratories International's Quick Ratio has ranged from 1.02 to 1.78. According to the industry distribution chart, Charles River Laboratories International ranks #153 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 71.2%.
Is Charles River Laboratories International's Quick Ratio too high?
Charles River Laboratories International's current Quick Ratio of 1.03 is 15% below median its 10-year median of 1.21. Over the past 10 years, this metric has ranged from a low of 1.02 to a high of 1.78. The Medical Diagnostics & Research industry median Quick Ratio is 1.73. Charles River Laboratories International's value of 1.03 is 40.5% below this industry median. Based on the distribution chart, Charles River Laboratories International ranks #153 out of 215 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Quick Ratio compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #153 out of 215 companies for Quick Ratio. This places Charles River Laboratories International in the lower half of its industry. The industry median Quick Ratio is 1.73. Charles River Laboratories International's value of 1.03 is 40.5% below this benchmark. Historically, Charles River Laboratories International's own Quick Ratio has ranged from 1.02 to 1.78 over the past decade. While the company's 10-year median is 1.21 vs. the industry median of 1.73, Charles River Laboratories International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.73, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Charles River Laboratories International's current Quick Ratio of 1.03 is 40.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Charles River Laboratories International and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charles River Laboratories International's current Quick Ratio is 1.03, which is 15% below median its own 10-year median of 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Quick Ratio of 1.03. The stock's GF Value™ is €121.29, compared to a current price of €143.90 — trading 18.6% above its estimated fair value. The current Quick Ratio is 1.03, which is 15% below median its 10-year median of 1.21 and 40.5% below the Medical Diagnostics & Research industry median of 1.73. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Quick Ratio is 1.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?
Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued.
The current stock price of €143.90 is trading 18.6% above its estimated GF Value™ of €121.29.
Key valuation signals for MIL:1CRL:
Quick Ratio: 1.03 (15% below median its 10-year median of 1.21)
GF Value™: €121.29 vs. price of €143.90 (18.6% above fair value)
Industry Position: 40.5% below the Medical Diagnostics & Research median (#153 of 215)
No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charles River Laboratories International Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score
Get the complete analysis for MIL:1CRL
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1CRL has been successfully added to your 
